Alembic Pharma PAT at Rs 169.29 cr. in Q2FY22
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
The company will provide the technical and financial resources to support the study
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The new facility will provide an important boost to vaccine capacity in Africa
The company has operations in North America, Asia, and Europe,
Subscribe To Our Newsletter & Stay Updated